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Establishment of Brody Memorial Lectureship 
A committee was appointed by Dean Longwell to consider the possibility of cre-
ating a memorial for Samuel Brody. It was the opinion of the committee that a per-
manent lectureship would be most suitable if sufficient funds were obtained from 
friends, relatives, organizations and the University Faculty invited to contr ibute to 
this memorial. 
Friends, relatives and organizations interested in recognizing Dr. Brody provided 
the initial funds, which were supplemented by a generous grant from the King Ranch 
and matching funds from the Alumni Achievement Funds. 
The Board of Curators approved the es t abli shment o f the Sam uel Brody 
Lectureship Fund in April 1959. Lectures have been held as often as sufficient 
income from the interest provided expenses and a small honorarium for a distin-
guished lecturer. 
The current Brody Memorial Lectureship Committee was appointed by Dean 
Roger Mitchell : 
Dr. Donald E. Spiers, Sigma Xi Representative 
Dr. Harold D. Johnson, Department of Animal Sciences 
Dr. B. Ann Becker, ARS Representative 
Dr. Ralph R. Anderson, Gamma Sigma Delta Representative 
The Committee welcomes additional contributions from individuals or groups 
in academia or industry. Such funds will be applied to the principal or endowment 
of the now-established Brody Memorial Lectureship Fund . Any increases in the 
endowment fund , or course, will allow lectures to be held more frequently. 
Previous Brody Lectures: 
I. Max Kleiber, Dept. Animal Science, Univ. of Calif., Berkeley, 1960 
II. Knut Schmidt-Nielsen, Dept. Zoology, Duke Univ. , 1961 
III. F. W. Went, Director, Missouri Botanical Garden, 1963 
IV. K. L. Baxter, Dept. Nutrition, Hannah Dairy Research Institute, 1964 
V. C. Ladd Prosser, Dept. Physiol. , Univ. of Illinois, 1965 
VI. H. T. Hammel, Physiol. Group, John B. Pierce Found. Lab., 1966 
VII. H. N. Munro, Dept. Physiol. Chemistry, Mass. Institute of Tech., 1967 
VIII. James D. Hardy, Dept. Physiol. , Yale University, 1968 
IX. Loren D. Carlson, Dept. Physiol., Univ. of Calif.-Davis, 1969 
X. R. L. Baldwin, Dept. Animal Science, Univ. of Calif.-Davis , 1971 
XI. John R. Brobeck, Dept. Physiol. , School of Medicine, Univ. of Penn., 1972 
XII. Bruce A. Young, Dept. Animal Science, Univ. of Alberta, 1974 
XIII . D. E. Johnson, Dept. Animal Science, Colorado State Univ., 1975 
XIV. Albert L. Lehninger, Dept. Physiol. Chern ., The Johns Hopkins School of 
Medicine, Baltimore, 1976 
XV. Henry A. Lardy, Dept. Bioi. Science, Univ. of Wisc.-Madison, 1979 
XVI. H. A. Tucker, Depts. Dairy Science and Physiol. , Mich. State Univ. , 1981 
XVII. H. Russell Conrad, Dept. Dairy Science, The Ohio State Univ., 1982 
XVIII . David Robertshaw, Dept. Physiol/Biophysics , Colorado State Univ., 1984 
XIX. Allen Munck, Dept. Physiol., Dartmouth Medical School, 1986 
XX. Lawrence J. Machlin, Dir. Clinical Nutrition, Vitamins and Fine Chemicals 
Division, Hottman-LaRoche Inc., 1988 
XXI. Keith W. Kelley, Dept. Animal Science, Univ. of Illinois, 1992 
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Introduction 
I am very honored to be invited to give the 22nd Brody Memorial 
Lecture. As a graduate student I was much influenced by the second, 
third and fourth lectures that I attended . Sam Brody, in his book 
"Bioenergetics and Growth," discussed many aspects of physiology 
including functions of hormones. In the early '40s, when he was writ-
ing the section on hormones, there was much to be discovered about 
growth hormone, as indicated by the quote below: 
The above discussion does not answer the question as to 
whether or not there is anterior-pituitary hormone acting 
directly on body growth (independently of other target 
glands), as is believed by Evans. General agreement will proba-
bly be delayed until (1) the pure A.P. growth hormone (if such 
is present) is obtained, and (2) it is demonstrated that it does 
not act on other endocrines, or that it stimulates growth in the 
absence of other endocrines or hormone-perhaps an impos-
sible demonstration since growth is an overall process, the 
resultant of innumerable interrelated factors . It therefore 
seems most logical to assume that growth is a function of 
many hormones, not of one specific growth hormone. 
The most interesting agricultural feature of the claimed 
effect of A.P. "growth hormone" injection in young animals is 
the increase in growth rate and ultimate body size in general 
and protein retention in particular. The ultimate body size fol-
lowing A.P. "growth hormone" injection is apparently not larg-
er than can be obtained by proper dietary means. The impor-
tant claim, somewhat difficult to accept, is that on a given 
quantity of the same food , when the animals are said to be 
"pair fed" (see Ch. 20), animals treated with A.P. extract grow 
faster in weight (from Brody, 1945). 
Clearly much information about growth hormone or somatotropin 
(ST) has been developed after this was written. The pure hormone has 
been produced in mass quantities, and many direct and indirect 
effects of ST have been demonstrated. Some of these effects are the 
subject of my lecture. 
By 1946, the pituitary was known to synthesize a variety of pep-
tide hormones including thyroid-stimulating hormone (TSH), follicle-
stimulating hormone (FSH), luteinizing hormone (LH), lactogenic hor-
mone (pro lactin), adrenocorticotropin (ACTH) and growth 
hormone/somatotropin. The characterization of those peptides has 
taken many years, and only recently have the controls for their release 
been partially unraveled. 
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Somatotropin physiology and biochemistry has been of interest 
for many years. By 1886, it had been established that acromegaly was 
associated with malfunction of the pituitary and that hypophysectomy 
resulted in growth retardation. The presence of a growth-promoting 
hormone in the pituitary gland was recognized as early as 1912 by 
Cushing. In 1921 , Evans and Long demonstrated a direct relationship 
between growth rate and the pituitary when they reported that an 
injection of a saline extract from bovine pituitary glands stimulated 
skeletal growth in rats. In 1927, Smith demonstrated that skeletal 
growth was stimulated by injection of bovine pituitary extract in 
hypophysectomized rats . He also reconfirmed the findings of Evans 
and Long that oral administration of ground bovine anterior pituitary 
tissue given to rats had no effect on growth. These early studies, for 
the most part, suggested that the pituitary gland secreted a substance 
that regulated somatic growth and development, and this substance 
became known as growth hormone or somatotropin. 
Much of the actual experimental evidence of ST's physiological 
effects was demonstrated after the preparation of highly purified 
bovine ST by Li and Evans in 1944 and by Fishman et al., in 1947. The 
previous observations made with the use of crude extracts were con-
firmed with purified ST. 
Recent advances in molecular biology have facilitated production 
of large quantities of recombinant hST. As a consequence, the produc-
tion of pituitary hST for treatment in humans is no longer necessary. 
Goedde! et al., in 1979 first expressed hST in E. coli using recombinant 
DNA technology. Its growth-promoting properties were effective over a 
range of doses, and prospects of being clinically useful were evident. 
Recombinant hST has become an effective drug for treatment of ST 
deficiency syndromes. A recent interest is the biology of ST in adults, 
and consequently, new information about effects of ST treatment after 
linear growth has been completed is rapidly becoming available. 
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Somatotropin and Lactation 
One physiological action of ST that has been known for many 
years is its influence on lactation. While some of the very early obser-
vations of activity were made in rabbits , Azimov and Krouze (1937) 
demonstrated in the 1930s using hundreds of cows that partially puri-
fied ST from bovine pituitaries would increase milk production . The 
response was replicated over the years and was also shown in goats, 
ewes, sows, etc. The mechanisms for these lactation responses are 
numerous (Bauman, 1990), and include indirect e ffects such as (1) 
enhanced nutrient supply to the mammary gland, (2) increased mam-
mary secretory cell synthesis rates leading to increased milk secretion 
driven mainly by the increased insulin-like growth factor-) OGF-1) and 
associated changes in IGF-1 binding proteins and (3) favorable mineral , 
kinetics, e.g., Ca. Direct actions of ST, such as the probable reduction 
in the gene expression of the membrane glucose transport protein 
Glut-4 in adipose tissue by ST, is an important repartition mechanism 
resulting in increased metabolites for milk secretion. Other ST actions 
on rena l 25-hydroxyvitamin D-1-hydroxylase activity that lead to 
increased Ca and P absorption from the intestine and reabsorption of 
P in renal tubules provides a means for meeting the increased mineral 
demands associated with increased milk production. BST has been 
shown to enhance not only milk production but the efficiency of pro-
duction primarily by reducing the nutrient proportion for maintenance 
and increasing that for milk production (Bauman, 1990). 
Somatotropin and Reproduction 
The use of ST in mature cattle is associated with several observ-
able changes in reproductive parameters. Treatment of lactating or 
nonlactating cattle with ST increased follicular development (De La 
Sota et. al., 1991 ; Gong et al. , 1991). This was apparently not associat-
ed with an increase in circulating gonadotropins or gonadotropin 
receptor levels (Gong et al., 1991). However, plasma and follicular IGF-1 
concentrations were increased in cattle treated with bST (Lucy et al., 
1992), indicating possible involvement of the somatomedin family in 
the increase in follicular development. Currently, it is not known 
whether bST acts locally to increase follicular IGF-1 concentrations or 
whether IGF-1 is taken up from plasma. However, the correlation 
between plasma and follicular IGF-1 concentrations is relatively high 
(Spicer et al., 1992). The ST receptor is present in large but not small 
luteal cells and is undetectable in follicular tissue (Lucy et al., 1993). 
Collectively, these results support an indirect rather than local effect 
of ST on follicular development. However, there may be direct effects 
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of ST on the corpus luteum. As stated previously, the large luteal cell 
contains abundant message for the ST receptor (Lucy et al. , 1993) , and 
treatment of cattle with bST increased the size of the corpus luteum 
(Lucy et al., 1992) . However, effects of ST on the concentration of prog-
esterone in plasma have been equivocal with repor ts of increased 
progesterone in some studies and no change in others (Gallo and 
Block, 1991 ; Cole et al. , 1991). This may be related to the stage of the 
estrus cycle in which animals were started on ST, but this hypothesis 
has not yet been tested . 
Other effects of ST treatment on lactating cattle include delayed 
conception in controlled studies where the breeding interval was 
extended (Cole et al., 1991) and a slight increase in multiple births in 
some herds . The mechanism responsible for the increase in twinning 
may be related to the increase in follicular development, although this 
has not yet been tested. The delay in conception in ST-treated animals 
is directly related to the adjustment period required for animals to 
shift their feed intake and energy balance to the increase in milk yield . 
The resulting intercalving interval was approximately 13 months . No 
effects of ST on fetal loss were detected (Cole et al. , 1991). 
In recent experiments with pST and gestating gilts, both embryo 
survival and muscularity of embryos and pigs were increased (Kelley 
et al., 1992 and 1993). Gilts were treated with pST during days 28-39 of 
gestation, a period during which embryonic resorption and formation 
of primary myofibers occurs. On day 40, treated gilts, compared to 
controls, had 2.3 more embryos per litter and increased crown-rump 
lengths. The embryos showed evidence of changes in myogenic gene 
activity associated with pST treatment. Pigs from gilts similarly treat-
ed compared to pigs from control gilts had heavier semitendinosis 
muscles and larger longissimus muscle cross-sectional areas. The 
authors concluded that early embryonic development processes are 
sensitive to manipulation through treatment of gestating gilts. 
Other ST Effects in Adult Mammals 
Somatotropin secretion diminishes after maturity, and thus many 
of the activities of ST in juveniles are greatly curtailed in adults. In 
terms of nutrient partitioning, older animals, including people, have 
increased fat deposition and decreased muscle mass (Rudman et al., 
1991) . This is reversible, at least in part, by ST supplementation 
(Christiansen et al., 1991). Bone mineral density is clearly decreased in 
long-standing ST deficiency in man (Bouillon, 1991). There is evidence 
that bone content and density are enhanced by supplemental ST in 
some but not all ST-deficient patients. Adult dogs treated with large 
doses of ST showed increases in bone formation at both peritoneal 
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and endosteal surfaces , resulting in a net increase of total skeletal 
mass (Harris et al. , 1972). ST treatment also increased bone mass in 
obese Zucker rats (Martinet al., 1989). The potential use of ST in frac-
ture repair is being studied because ST stimulates bone cell growth 
and function (Bak and Andreassen, 1991). This application and one for 
treating osteoporosis are likely to provide benefits where ST deficien-
cy is present due to pituitary disease or as a part of the aging process . 
It has been concluded that other factors must contribute to the age-
related decline in fracture repair because ST supplementation only 
partially replenishes this function to that of young animals. 
Somatotropin is now known to have immunomodulatory effects . 
Susceptibility to infections , neoplastic diseases and autoimmune dis-
eases may be influenced by ST status . Part of the aging process 
includes a diminution of immune function and is associated with atro-
phy of the thymus gland (Khansari and Gustad, 1991). Macrophages 
have been primed by ST for production of superoxide anions (Kelley, 
1989). Furthermore, polymorphonuclear neutrophil (PMN) adhesive-
ness may be stimulated by ST (Wiedermann et al. , 1991). Supplemental 
ST in healthy adult humans increased natural killer cell activity indi-
cated by an increase in the percent specific lysis of K562 tumor target 
cells. 
Treatment of adult animals with ST has led to some positive 
effects on immune function. Bovine ST treatment of 3- to 5-year-old 
dogs resulted in regeneration of thymic morphology, presumably, in 
part, through the action of increased production of thymulin (Goff et 
a!., 198 7). Enhanced in vivo host protection against Salmonella 
typhimurium in rats treated with ST was reported by Edwards et al. 
(1989). Immune function and life expectancy of Balb/c mice treated 
with a low dose of hST was studied by Khansari and Gustad (1991). 
The mice were treated with ST starting at 1 7 months of age after signs 
of senescence and casual death occurred. There were no significant 
differences between cytokine production (IL-l, IL-2, TNF and lgG) in 
the young and ST-treated groups, but the old, untreated group had 
diminished IL-2. ST-treated mice had higher IL-l and TNF production 
rates and significantly reduced mortality compared with the old , 
untreated mice. The authors postulated that the apparent prolonga-
tion of the mean life expectancy by ST treatment was due to a delay or 
prevention of age-associated disorders. It is not clear yet whether the 
responses observed were specific for the strain of mice selected for 
the study. 
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Summary 
Only recently has an interest developed in the physiologic impor-
tance of ST in adults, and therefore, little is known about effects of ST 
treatment after linear growth has been completed. One exception to 
this is the well-established enhancement of lactation in cows. 
Increased milk yield is now known to be a typical response to exoge-
nous ST in mammals, and higher-producing cows have greater secre-
tion rates of ST. Aside from the effects on lactation and reproduction, 
many of the other actions of ST in adult mammals are suppression or 
regression of processes associated with aging. ST and insulin-like 
growth factor-! concentrations diminish with age, and these changes 
may permit initiation of many processes of aging. Examples of the 
effects of ST supplementation in aging animals and humans include 
increased muscling, reduced adipose tissue, liver regeneration and 
increased basal metabolic rate. ST stimulates (1) bone turnover via 
increased osteoblast number and function and, thus, bone resorption 
and (2) renal 25-hydroxyvitamin 0-la-hydroxylase activity, thus 
increasing Ca and P absorption from the intestine and the reabsorp-
tion of P in renal tubules . The healing of both bone and certain types 
of wounds are enhanced by ST treatment in adults . ST has been shown 
in adult animals to cause increased thymulin and the reversal of the 
thymus atrophy associated with aging. In aging mice, a long-term, low-
dose therapy with ST improved immune function and prolonged life 
span. Although there are no reported direct side effects, at least in lac-
tating cows, it is possible that , in man, potential undesirable side 
effects associated with ST therapy, such as hyperglycemia and 
increased organ size, can be controlled by careful management of ST 
dose. Presumably there are other important factors in the aging 
process, but it seems likely that replacement therapy to maintain the 
higher ST levels present during early adulthood will diminish the 
onset of certain aspects of aging. 
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Biography of Clifton A. Baile 
Clifton A. Baile, Distinguished Fellow, Head of Animal Sciences/ Molecular 
Biology Division, Monsanto Agricultural Company, St. Louis, Mo. 
Dr. Baile was born in Warrensburg, Mo., on February 8, 1940. He graduated with 
a bachelor of science degree from Central Missouri State College in 1962 and 
earned his Ph.D., in nutrition from the University of Missouri in 1965 under the 
direction of Dr. William Pfander. His dissertation research on the regulation of feed 
intake in domestic animals has remained a lifelong interest. During his studies at 
the University of Missouri, Dr. Baile was awarded a Ralston Purina Fellowship. 
Dr. Baile accepted an NIH postdoctoral fellowship in the School of Public Health 
at Harvard University in 1964, and there he began pioneering techniques with Dr. 
Jean Mayer for the study of the hypothalamic regulation of feed intake in collabora-
tion. He was appointed instructor of nutrition in 1966 and assistant professor in 
1968. That same year, Dr. Baile joined Smith Kline Animal Health Products, where 
he was manager of neurobiological research. At the same time, he held the position 
of research associate at the Monell Chemical Senses Center and lecturer in nutri-
tion at the University of Pennsylvania. 
In 1975, Dr. Baile, accepted a position as associate professor of nutrition at the 
University of Pennsylvania, where he was promoted to professor in 1979. He joined 
the Nutrition Chemicals Division of the Monsanto Agricultural Company in 1982 as 
a senior fellow, where he implemented a program in new product identification. In 
February 1986, he was named direc tor of the New Product Identification 
Department, and in March 1987, he was appointed senior fellow and director of 
research and development of the Animal Sciences Division. In April 1988, Dr. Baile 
was appointed a distinguished fellow, one of only four scientists to hold this dis-
tinction in the approximately 3,500-member scientific community at Monsanto. 
Since 1985, Dr. Baile has held a position as adjunct professor of nutrition at the 
Washington University School of Medicine, where he has had a laboratory with NIH 
funding and has continued his investigation into the hypothalamic regulation of 
feed intake. In 1986, he was appointed adjunct professor of nutrition in the Animal 
Sciences Department at the University of Missouri. 
Dr. Baile's contribution to the literature on the relationship between growth, lac-
tation and the control of feed intake includes approximately 225 journal articles, 
reviews and chapters and a similar number of abstracts for scientific meetings. Dr. 
Baile received the American Feed Manufacturers Award for his research in dairy 
nutrition in 1979 and was the recipient of the 1989 ASAS Animal Growth and 
Development Award. 
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